|

Antibody-drug conjugate (ADC) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ADCE-D01

Pipeline

Phase 1/2: 1

Top Sponsors

  • Adcendo ApS1

Indications

  • Unresectable Soft Tissue Sarcoma1
  • Metastatic Soft-tissue Sarcoma1
  • Cancer1

Aurora, Colorado1 trial

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

University of Colorado Denver

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.